Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Market Capitalization	276	216	113	35	44	113
Market Cap Growth	-62.02%	91.16%	221.19%	-19.99%	-61.12%	200.36%
Enterprise Value	102	-48	98	-19	-14	49
Last Close Price	3.90	3.19	4.02	2.47	3.09	7.98
PS Ratio	227.48	148.28	78.65	6.49	-	11.23
PB Ratio	1.09	0.74	1.50	0.64	0.72	1.68
P/TBV Ratio	1.34	0.90	147.82	0.64	0.72	1.68
EV/Sales Ratio	82.28	-	68.42	-	-	4.86
Debt / Equity Ratio	0.01	0.01	0.03	-	0.01	0.01
Asset Turnover	0.00	0.01	0.02	-	-	0.25
Inventory Turnover	-	-	-	-	-	6.07
Quick Ratio	14.77	12.53	0.67	14.47	25.38	36.58
Current Ratio	15.09	12.68	1.08	17.07	26.18	37.37
Return on Equity (ROE)	-31.47%	-42.82%	-57.70%	-	-9.79%	-9.26%
Return on Assets (ROA)	-15.32%	-19.02%	-32.81%	-	-5.95%	-5.43%
Return on Capital (ROIC)	-17.38%	-22.42%	-38.66%	-	-6.17%	-5.73%
Earnings Yield	-32.78%	-36.77%	-41.23%	-30.64%	-16.57%	-3.00%
FCF Yield	-39.63%	-33.72%	-33.68%	-30.42%	-18.17%	-2.85%
Buyback Yield / Dilution	-67.21%	-140.72%	-88.38%	-0.06%	-36.73%	-53.61%

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q